Table 1 Summary of the binding kinetics of anti-mCD27 antibodies
From: Harnessing multivalency and FcγRIIB engagement to augment anti-CD27 immunotherapy
Antibody | Ka (×106 M−1s−1) | Kd (×10−3 s−1) | Apparent affinity (KD, ×10−9 M) |
|---|---|---|---|
Anti-mCD27 mIgG1 | 1.3 | 12.7 | 9.5 |
Anti-mCD27 mIgG1 NQ | 1.1 | 14.4 | 13.1 |
Tetra anti-mCD27 mIgG1 | 1.6 | 2.9 | 1.8 |
Tetra anti-mCD27 mIgG1 NQ | 1.6 | 2.4 | 1.5 |